Arthur H. Jeske, DMD, PhD, is the Associate Dean for Strategic Planning and Continuing Dental Dducation and a professor in the Department of General Practice and Dental Public Health at The University of Texas School of Dentistry at Houston. He earned his PhD in pharmacology and DMD from the Medical College of Georgia. He is a member of the American Dental Association (ADA), Texas Dental Association, and Greater Houston Dental Society and is a fellow of the International College of Dentistry and the American College of Dentistry. Dr. Jeske chaired the ADA's Council on Scientific Affairs in 2004 and has authored numerous articles on the use of drugs in dentistry. He is currently editor-in-chief of Mosby's Dental Drug Reference and an editor of Contemporary Dental Pharmacology.

Nadarajah Vigneswaran, BDS, DMD, DrMedDent, is a professor in the UTHealth School Dentistry in the Department of Diagnostic and Biomedical Sciences. He earned a Dr.Med.Dent in Immunopathology at University of Erlangen, Germany and a DMD at UAB School of Dentistry. He completed his residency in Oral and Maxillofacial Pathology at the Emory University School of Medicine and his Dental Oncology Fellowship at the UAB School of Dentistry. He is an oral and maxillofacial pathologist who is involved in the diagnosis and management of patients with various oral mucosal disorders. He directs the UTSD-Houston Oral and Maxillofacial Pathology Biopsy service, which process approximately 5,000 cases per year, and is one of the largest biopsy services for the dental profession, in this country. He is actively involved in both clinical and laboratory-based research, related to oral cancer and its precursors. His clinical research focuses on evaluating non-invasive diagnostic devices for early diagnosis of oral cancer and its precursor lesions. His basic research involves the development of experimental animal models for pre-clinical testing of molecular targeted diagnostic imaging and therapy. He also has more than 120 peer reviewed scientific publications in high-impact journals and 6 chapters in medical dental textbooks. He has been an invited presenter for national and international research conference and received over $ 7.5 million in grant funding from Federal (NIH), State (CPRIT) and Local (UTHealth CTSA Consortium) as a principal- and co-investigator.